SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Phoenix, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Follow-Up Questions
Senestech Inc의 CEO는 누구입니까?
Mr. Joel Fruendt은 2022부터 회사에 합류한 Senestech Inc의 President입니다.
SNES 주식의 가격 성능은 어떻습니까?
SNES의 현재 가격은 $3.76이며, 전 거래일에 decreased 0% 하였습니다.
Senestech Inc의 주요 사업 주제나 업종은 무엇입니까?
Senestech Inc은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
Senestech Inc의 시가총액은 얼마입니까?
Senestech Inc의 현재 시가총액은 $18.5M입니다
Senestech Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Senestech Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 4명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다
